C-reactive protein, insulin resistance, and metabolic syndrome in a population with a high burden of subclinical infection: Insights from the genetics of coronary artery disease in Alaska natives (GOCADAN) study

Diabetes Care

Volumn 31, Issue 12, 2008, Pages 2312-2314

  Howard, Barbara V ^a   Best, Lyle ^b   Comuzzie, Anthony ^c   Ebbesson, Sven O E ^d   Epstein, Stephen E ^a   Fabsitz, Richard R ^e   Howard, Wm James ^f   Silverman, Angela ^a   Wang, Hong ^a   Zhu, Jianhui ^a   Umans, Jason ^a  

^a MEDSTAR RESEARCH INSTITUTE   (United States)

^b MISSOURI BREAKS INDUSTRIES RESEARCH INC   (United States)

^c SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^d Norton Sound Health Corporation   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HOMOCYSTEINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INSULIN;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; DIET RESTRICTION; DIETARY INTAKE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFECTION; INSULIN RESISTANCE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHYSICAL EXAMINATION; URINALYSIS; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INUITS; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 64349086585     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-0815     Document Type: Article

References (15)

1. Pradhan AD, MansonJE, Rifai N, Buring JE, Ridker PM: C-reactive protein, inter- leukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327-334, 2001
2. SprangerJ, Kroke A, Mohlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF: Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52:812-817, 2003
3. Festa A, D'Agostino R Jr, Tracy RP, Haffner SM: Elevated levels of acute- phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes 51:1131-1137, 2002
4. Lanier AP, Ehrsam G, Sardidge J: Alaska Native mortality 1989-1998. Anchorage, Alaska, Office of Alaska Native Health Research, Division of Community Health Services, Alaska Native Tribal Health Consortium, 2002
5. Zhu J, Katz RJ, Quyyumi AA, Canos DA, Rott D, Csako G, Zalles-Ganley A, Ogun- makinwa J, Wasserman AG, Epstein SE: Association of serum antibodies to heat-shock protein 65 with coronary calcification levels: suggestion of pathogen-triggered autoimmunity in early atherosclerosis. Circulation 109:36-41, 2004
6. Carter EA, MacCluer JW, Dyke B, Howard BV, Devereux RB, Ebbesson SO, Resnick HE: Diabetes mellitus and impaired fasting glucose in Alaska Eskimos: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study. Diabetologia 49:29-35, 2006
7. Howard BV, Devereux RB, Cole SA, Davidson M, Dyke B, Ebbesson SO, Epstein SE, Robinson DR, Jarvis B, Kaufman DJ, Laston S, MacCluer JW, Okin PM, Roman MJ, Romenesko T, Ruotolo G, Swenson M, Wenger CR, Williams-Blangero S, Zhu J, Saccheus C, Fabsitz RR, Robbins DC: A genetic and epidemiologic study of cardiovascular disease in Alaska natives (GOCADAN): design and methods. Int J Circumpolar Health 64:206-221, 2005
8. Nobmann ED, Ponce R, Mattil C, De- vereux R, Dyke B, Ebbesson SO, Laston S, MacCluer J, Robbins D, Romenesko T, Ruotolo G, Wenger CR, Howard BV: Dietary intakes vary with age among Eskimo adults of northwest Alaska in the GOCADAN study, 2000-2003. J Nutr 135:856 -862, 2005
9. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Ho- meostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
10. Shoelson SE, Herrero L, Naaz A: Obesity, inflammation, and insulin resistance. Gastroenterology 132:2169-2180, 2007
11. Duncan BB, Schmidt MI: The epidemiology of low-grade chronic systemic inflammation and type 2 diabetes. Diabetes Technol Ther 8:7-17, 2006
12. Ford ES: Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 22:1971-1977, 1999
13. Tutor CG: C-reactive protein and diabetes in three American Indian populations: The Strong Heart Study. Master thesis. Norman, Oklahoma, The University of Oklahoma, 2001.
14. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N: C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 51:1596 -1600, 2002
15. Duncan BB, Schmidt MI, Pankow JS, Bal- lantyne CM, Couper D, Vigo A, Hoo- geveen R, Folsom AR, Heiss G: Low-grade systemic inflammation and the development of type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes 52:1799-1805, 2003